|
⚲
|
| Keyboard |
| Chromocell Therapeutics Corp | |
|---|---|
| Ticker | PTHS |
| CIK # | 0001919246 |
| CUSIP | 171126204 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 685 US Highway One, North Brunswick, NJ 08902 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Pelthos Therapeutics Inc | 2025-11-19 | 18.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Chromocell Therapeutics Corp | 2024-08-06 | 0.8 M | Exemption: 506(b) · Duration: One year or less · Revenue: No Revenues |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001919246] | 10-K | |
| [0001919246] | 10-Q | |
| [0001919246] | 3 | |
| [0001919246] | 4 | |
| [0001919246] | 8-K | |
| [0001919246] | D | |
| [0001919246] | SC 13D | |
| [0001919246] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Einhorn Andrew J
Common Stock
|
2025-12-23 | Grant | 12,000 | ||
|
Ligand Pharmaceuticals Inc
Senior Secured Convertible Note · derivative
|
2025-12-17 | Grant | |||
|
Ligand Pharmaceuticals Inc
Senior Secured Convertible Note · derivative
|
2025-12-17 | Disposed to issuer | |||
|
Pauls Matthew
Common Stock
|
2025-12-10 | Gift | 9,542 | $0.00 | |
|
Friedberg Ezra M
Common Stock
|
2025-11-25 | Sell | 2,000 | $28.01 | 56,020 |
|
Friedberg Ezra M
Common Stock
|
2025-11-25 | Sell | 2,000 | $28.14 | 56,280 |
|
Friedberg Ezra M
Common Stock
|
2025-11-25 | Sell | 1 | $28.50 | 28 |
|
Friedberg Ezra M
Common Stock
|
2025-11-25 | Sell | 5,999 | $28.00 | 167,972 |
|
Ligand Pharmaceuticals Inc
Senior Secured Convertible Note · derivative
|
2025-11-06 | Grant | $9,000,000.00 | ||
|
Pauls Matthew
Common Stock
|
2025-10-02 | Option exercise | 2,123 | $0.00 | |
|
Pauls Matthew
Restricted Stock Units · derivative
|
2025-10-02 | Option exercise | 2,123 | $0.00 | |
|
Baxter Richard B
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 19,108 | ||
|
Baxter Richard B
Stock Option · derivative
|
2025-07-02 | Grant | 58,230 | ||
|
Greenleaf Peter
Stock Option · derivative
|
2025-07-02 | Grant | 77,640 | ||
|
Greenleaf Peter
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 25,478 | ||
|
Pauls Matthew
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 25,478 | ||
|
Pauls Matthew
Stock Option · derivative
|
2025-07-02 | Grant | 77,640 | ||
|
Francis Knuettel II
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 33,472 | ||
|
Francis Knuettel II
Stock Option · derivative
|
2025-07-02 | Grant | 102,000 | ||
|
Davis Todd C
Stock Option · derivative
|
2025-07-02 | Grant | 58,230 | ||
| showing 20 of 74 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 17 | 912,311 |
| 2025-12-31 | 15 | 899,359 |
| 2025-09-30 | 14 | 462,763 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 40 | Prev | Page 1 | Next |